Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.

by Shannon M Lenz, Jaymes H Collins, Nashone A Ray, Deanna A Hagge, Ramanuj Lahiri, Linda B Adams
Published 2020-09-01

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy

by Shannon M. Lenz, Jaymes H. Collins, Nashone A. Ray, Deanna A. Hagge, Ramanuj Lahiri, Linda B. Adams, Susilene Maria Tonelli Nardi
Published 2020-09-01